Herschler GB - Search Results

1

Every nose counts: a new influenza vaccine for all healthy schoolchildren?

Gaglani MJ, Herschler GB. Gaglani MJ, et al. Among authors: herschler gb. Clin Pediatr (Phila). 2004 Jan-Feb;43(1):35-41. doi: 10.1177/000992280404300105. Clin Pediatr (Phila). 2004. PMID: 14968891 Review.

2

Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial.

Piedra PA, Gaglani MJ, Riggs M, Herschler G, Fewlass C, Watts M, Kozinetz C, Hessel C, Glezen WP. Piedra PA, et al. Pediatrics. 2005 Sep;116(3):e397-407. doi: 10.1542/peds.2004-2258. Pediatrics. 2005. PMID: 16140685 Free PMC article. Clinical Trial.

3

Safety of the intranasal, trivalent, live attenuated influenza vaccine (LAIV) in children with intermittent wheezing in an open-label field trial.

Gaglani MJ, Piedra PA, Riggs M, Herschler G, Fewlass C, Glezen WP. Gaglani MJ, et al. Pediatr Infect Dis J. 2008 May;27(5):444-52. doi: 10.1097/INF.0b013e3181660c2e. Pediatr Infect Dis J. 2008. PMID: 18401289

4

Direct and total effectiveness of the intranasal, live-attenuated, trivalent cold-adapted influenza virus vaccine against the 2000-2001 influenza A(H1N1) and B epidemic in healthy children.

Gaglani MJ, Piedra PA, Herschler GB, Griffith ME, Kozinetz CA, Riggs MW, Fewlass C, Halloran ME, Longini IM Jr, Glezen WP. Gaglani MJ, et al. Among authors: herschler gb. Arch Pediatr Adolesc Med. 2004 Jan;158(1):65-73. doi: 10.1001/archpedi.158.1.65. Arch Pediatr Adolesc Med. 2004. PMID: 14706961 Clinical Trial.

5

Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children.

Piedra PA, Gaglani MJ, Kozinetz CA, Herschler GB, Fewlass C, Harvey D, Zimmerman N, Glezen WP. Piedra PA, et al. Among authors: herschler gb. Pediatrics. 2007 Sep;120(3):e553-64. doi: 10.1542/peds.2006-2836. Epub 2007 Aug 13. Pediatrics. 2007. PMID: 17698577 Clinical Trial.

6

Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children.

Piedra PA, Gaglani MJ, Kozinetz CA, Herschler G, Riggs M, Griffith M, Fewlass C, Watts M, Hessel C, Cordova J, Glezen WP. Piedra PA, et al. Vaccine. 2005 Feb 18;23(13):1540-8. doi: 10.1016/j.vaccine.2004.09.025. Vaccine. 2005. PMID: 15694506 Clinical Trial.

7

Estimating efficacy of trivalent, cold-adapted, influenza virus vaccine (CAIV-T) against influenza A (H1N1) and B using surveillance cultures.

Halloran ME, Longini IM Jr, Gaglani MJ, Piedra PA, Chu H, Herschler GB, Glezen WP. Halloran ME, et al. Among authors: herschler gb. Am J Epidemiol. 2003 Aug 15;158(4):305-11. doi: 10.1093/aje/kwg163. Am J Epidemiol. 2003. PMID: 12915495

8

Efficacy of trivalent, cold-adapted, influenza virus vaccine against influenza A (Fujian), a drift variant, during 2003-2004.

Halloran ME, Piedra PA, Longini IM Jr, Gaglani MJ, Schmotzer B, Fewlass C, Herschler GB, Glezen WP. Halloran ME, et al. Among authors: herschler gb. Vaccine. 2007 May 16;25(20):4038-45. doi: 10.1016/j.vaccine.2007.02.060. Epub 2007 Mar 12. Vaccine. 2007. PMID: 17395338 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters